PROM1 and glioblastoma: Data indicate that knockdown of PDGFRB and c-Kit expression in glioblastoma multiforme cells leads to inhibited CD133 expression and a normal-like cell cycle distribution driven by the MAPK/ERK signaling pathway rather than the PI3K/AKT pathway (68).